Additional ideas / future partners for our Research Institute

Start discussions on "transitional" pharmaceutical business model

R&D in tropical diseases is still not at the right level - can we correct this?

How to involve DECs in R&D in drug research?

Discover, develop and deliver new medicines to fight malaria

Facilitate the South to set her own research agenda

Use human resources available in South and experience of North to collaborate on drug discovery and development

Create more partnerships

Use best practice model, expand into other areas

Community needs must be focus, beneficiary and determinant of research

Commitment to partnership

Formal commitments

Funding / financial implications for partnerships

Monitoring tools for R&D

Re-evaluate partnership timeframes

Monitoring and evaluation tools / mechanisms

Scenario of success stories (partnerships)

Best practice of North-South partnership model achieved

Guidelines (future)

Levels for formalizing agreements

Provide guidelines for mutually beneficial partnerships

Share ownership of research with partners: researchers and [the] researched

A common understanding of partnership in research

Guidelines for partnership in research

Status of working relationships (criteria)

A process to bring private or public enterprises together to address disease related problems in the developing world

Have same understanding of R&D

Mechanisms for facilitating partnerships

Pan-African training centre for health scientists

Innovation to support research institutions in developing countries in a sustainable manner

Develop capacity in transitional countries to do pharmaceutical discovery at low cost, especially in tropical diseases

Global Fund ATM should also fund R&D (for outcome oriented research)

Other sources?

Developing country commitments to R&D will assure more effective partnerships

Ensure equal contribution from partners

Create R&D Trust Fund

Organise a forum to encourage private-public partnerships with specific financial resources and specific time bound goals

Establish links / collaboration between pharmaceutical companies and research institutions in endemic countries

Universities in developing countries have large potential. They should participate in research partnerships

Community involvement in partnerships

Advocate and lobby for guidelines for partnerships

Develop / adopt internationally recognized standards for partnership in research

Broaden the scope of partnerships to include Health Promotion and Health Systems research

Ensure accountability

Ensure long term partnerships

Create a well-reputed prize for excellence in partnership

Make [public] negative examples of non-respect of partnerships

Award for "Utilization of Research to the Benefit of the People"

Adopt or develop a website on good practices of partnerships in health research

Review existing North-South, South-South partnerships to identify best practices

Build business entities based on successful models for neglected diseases and high incidence disorders

All Environmental Impact Assessments should include Health Impact Assessment (Partnerships should take a leading role in HIA)

Existing initiatives (Novartis Singapore Institute)

Projects in Ghana and Tanzania

Contacts in India, Brazil and WHO

Lack of data to support business model

Lack required funding

Don't know which government would want to be champion

Initiatives to build drug discovery in Transitional countries (i.e. India, Brazil, etc.)

Sell interesting compounds to multi-nationals at later stage (Intellectual Property protection necessary)

Find support at home (Novartis management)

Independent fund free of political, governmental and economic influence

A potential for building trust amongst N-S partners

Organizational limitations

Administration

Create a R&D Trust Fund, which is independent and professionally managed.  The trustees shall be distinguished individuals from across the world.

Talent available in universities

Pharmaceutical companies

Public R&D institutions have capacity and manpower

MMV has expertise in R&D in Malaria

Intellectual property can create wealth in all countries including developing countries / LDC

Universities have little interaction with industry

Pharmaceutical companies not working on R&D for diseases of developing countries

No direction in public R&D institutions

Lack of awareness in several countries on intellectual property rights

Encourage developing countries to contribute to R&D (in modest volumes)

Identify specific areas of healthcare in each country where partnerships could be most effective

Get US support for the idea of partnership in health research

Models exist, not just in health sector

Awareness of its problems is widespread

Increasing southern demand for more equitable research partnerships

Contrary to attitude and practices of the past (.... and today)

Major efforts in capacity building are necessary

Having guidelines does not solve the underlying problems

Create inventory of existing guidelines and standards

Present good practices

Develop standards

Have standards approved by a international body

Disseminate standards and promote/ advocate them

....somebody has to take the initiative

Growing interest in partnership

The topic is very sensitive to some organizations

Identify institutions